Gynecology Products

A line of products designed to provide a gentle approach to the treatment of Inflammation and infections of the urinary tract, to prevent and treat problems of poor circulation, microcirculation, venous stasis and hemorrhoidal crisis, for the delicate Skin cleansing and intimate hygiene, and to provide an optimal Hydration and Protection of skin in pregnancy and not.













RSS American Journal of Obstetrics & Gynecology

  • Onabotulinumtoxin a injections for patients with pelvic floor dysfunction April 1, 2024
    It is estimated that about 50-90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, we generally recommend that patients start with pelvic floor physical therapy alone or in combination with pelvic trigger point injections with local anesthetic. We offer […]
    G Whitmore, J Tam, M Orlando
  • Retropubic versus single-incision mid-urethral sling for concomitant management of stress urinary incontinence during native tissue vaginal repair: a randomized clinical trial April 1, 2024
    Choice of mid urethral sling type may impact efficacy and complications in women undergoing transvaginal native tissue repair of multicompartment pelvic organ prolapse (POP).
    C Matthews, C Rardin, A Sokol, C Iglesia, S Collins, C Ferrando, H Winkler, K Kenton, J Geynisman-Tan, R Gutman
  • Hemi-hysterectomy for rudimentary horn ectopic pregnancy April 1, 2024
    Unicornuate uterus is caused by the non-development of one müllerian duct. The condition usually is associated with various degrees of rudimentary horn connected to the unicornuate uterus, when one of the ducts develops only partially. The horn can be communicating or non-communicating, leading to variable clinical presentations. Unicornuate uterus with pregnancy in the noncommunicating rudimentary […]
    A Mohr-Sasson, C Leidlein, A Bhalwal
  • Navigating the pelvis with müllerian anomalies April 1, 2024
    The prevalence of congenital uterine anomalies among the general population is estimated to be 5.5%. Some of the symptoms with these anomalies include pelvic pain and abnormal uterine bleeding although many patients can be asymptomatic. Müllerian anomalies have been associated with renal, skeletal, and abdominal wall anomalies with up to 30% of patients having coexisting […]
    G Rivera Ortiz, N Mahnert, J Mourad
  • Robotic assisted paraurethral fibroid excision via retzius space dissection April 1, 2024
    This video describes the diagnosis and management of a rare case of a paraurethral fibroid. Urethral and paraurethral fibroids have primarily been described in case reports and have a reported incidence of 5% of urethral masses. The primary management is surgical excision.
    P Coombs, O Cardenas-Trowers
  • Robotic-assisted resection of a rudimentary uterine horn April 1, 2024
    A unicornute uterus is a type of congenital uterine anomaly that results from malformation of the Mullerian ducts. This can lead to formation of a uterine horn which may become obstructed. This anomaly is associated with chronic pelvic pain and infertility. Management of uterine horn is often limited. However, for patients who suffer from chronic […]
    A Farrell, T Koi
  • Factors associated to the presence of isthmocele diagnosed by pelvic ultrasound, magnetic resonance imaging or diagnostic hysteroscopy: a cross-sectional study April 1, 2024
    Cesarean section is one of the most performed surgery around the world. Not only its rate is on the rise but also associated complications such as isthmocele and the related risk factors for developing isthmocele are unclear.
    JP Leonardo-Pinto, R Bellumoni, CL Benetti-Pinto, LGO Brito, DA Yela
  • Laparoscopic management of postabortion pyomyoma April 1, 2024
    Pyomyoma, or suppurative leiomyoma, is a rare gynecologic complication with high morbidity and mortality without prompt and appropriate treatment. Since 1945, the number of reported cases in the literature is less than 100 case reports and in most reported cases, surgical treatment is recommended with intravenous antibiotics (IV).
    S Parikh, M Lazenby, E Root, SM Lenger, S Francis
  • Man vs. machine: identifying chatGPT-generated abstracts in gynecology and urogynecology April 1, 2024
    The advent of ChatGPT, a publicly available artificial intelligence (AI) language model, has allowed for sophisticated AI technology on demand. With widespread access to AI writing, the medical community has yet to understand the capabilities and ethical considerations of AI chatbots in the context of scientific research.
    E Pan, M Florian-Rodriguez
  • LAPRO study: learning and acquisition of laparoscopic procedural skills in the operating room April 1, 2024
    Learning surgery is a complex cognitive and physical task that occurs within a multifaceted learning environment. Despite robust theoretical foundations within and beyond the field of medical education, our understanding of how surgical trainees learn to perform surgery in the operating room (OR) environment remains just that, largely theoretical.
    J Hall, J Young, A Brown, K Nelson
  • Sterilization surgery trends in texas after passage of the texas heartbeat act April 1, 2024
    On September 1, 2021, abortion became illegal in Texas once embryonic cardiac activity could be detected. Before that, elective abortions were allowed up to 20 weeks post-fertilization. The change in law led women seeking abortions to face logistical, emotional, and financial hardships. In order to primarily avoid unwanted pregnancy, a trend for younger women to […]
    A Mohr-Sasson, L Weitzel, S Carlisle, A Bhalwal
  • Association of Catechol-O-Methyltransferase (COMT) val158met genetic polymorphism and outcomes following sacral neuromodulation or onabotulinumtoxina in women with urgency irinary incontinence April 1, 2024
    The mechanism of action of neuromodulation (percutaneous tibial nerve stimulation [PTNS] or sacral neuromodulation [SNM]) for the treatment of urgency urinary incontinence and/or fecal incontinence is poorly understood. Previously we showed an association between the catechol-O-methyltransferase (COMT) Val158Met (rs4680) single nucleotide polymorphism (SNP) and PTNS response in women with fecal incontinence. We hypothesized that COMT […]
    M Florian-Rodriguez, H Richter, M Carnes, H Zyczynski, E Lukacz, A Visco, L Arya, V Sung, D Mazloomdoost, M Gantz
  • Patient perspectives in adverse event reporting after apical prolapse surgery April 1, 2024
    Many clinical trials use systematic methodology to monitor adverse events (AEs) determining grade (severity), expectedness and relatedness to treatments from the clinician perspective; however, there is a lack of input from the patient perspective.
    V Sung, S Menefee, H Richter, P Moalli, M Paraiso, U Andy, A Weidner, S Jeney, D Mazloomdoost, R Whitworth, J Gilbert, S Thomas
  • Pain without prejudice? examining disparities in endometriosis and pelvic pain management stratified by race in an integrative healthcare system April 1, 2024
    An estimatedApproximately 10% of reproductive age women suffer from endometriosis; however, racial variations in prevalence and treatment are unknown. Black women are often undertreated for pain and medical conditions.
    E Zaritsky, A Childs, E Hen, L Tucker, M Weintraub-Ritterman, C Wicks
  • Effectiveness & safety of a novel, collapsible pessary for management of pelvic organ prolapse April 1, 2024
    Pessaries are an effective treatment for pelvic organ prolapse, yet currently available pessaries can cause discomfort with removal and insertion. An early feasibility trial of an investigational, collapsible pessary (Figures 1A and 1B) previously demonstrated mechanical feasibility during a brief 15-minute office trial. Longer term, patient-centered safety and efficacy data is needed.
    K Strohbehn, P Wadensweiler, H Richter, C Grimes, C Rardin, P Rosenblatt, M Toglia, G Siddiqui